Phase 1 study of lenzilumab, a recombinant anti-human GM-CSF antibody, for chronic myelomonocytic leukemia.
Patnaik MM, Sallman DA, Mangaonkar AA, Heuer R, Hirvela J, Zblewski D, Al-Kali A, Binder M, Balasis ME, Newman H, Letson C, Kruer TL, Gangat N, Komrokji RS, Tefferi A, Lo A, Shih T, Durrant C, List AF, Padron E.
Patnaik MM, et al. Among authors: binder m.
Blood. 2020 Aug 13;136(7):909-913. doi: 10.1182/blood.2019004352.
Blood. 2020.
PMID: 32294158
Free PMC article.
Clinical Trial.
No abstract available.